All News

The American Board of Medical Specialties said it intends to create tools to promote the meaningful use of health information technology (HIT) and incorporate them into the ABMS Maintenance of Certification (MOC) program.

Mission Pharmacal Co. has announced the introduction of methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue, hyoscyamine sulfate (Uribel) capsules for oral administration to help relieve local discomfort and inflammation associated with lower urinary tract infections, interstitial cystitis, painful bladder syndrome, and pre- and post-diagnostic urinary tract procedures.

CO2 laser therapy, used in combination with robotic surgery, may reduce the risk of damaging nerves during prostatectomy, according to a small study by researchers at New York-Presbyterian Hospital/Columbia University Medical Center, New York.

A new study suggests that consuming specific compounds in meat related to processing methods may be associated with an increased risk of developing bladder cancer.

Surgery for localized prostate cancer offers a significantly higher survival rate than either external beam radiation or hormonal therapies, researchers from the University of California, San Francisco recently reported.

UrologyMatch.com, an Internet resource and online community designed to assist medical students, educators, and professionals in all aspects of studying and practicing urology, has launched an application to give users quick and easy access to the most commonly utilized areas of UrologyMatch.com.

A highly specific assay for the detection of a protein associated with tumor formations present in nearly two-thirds of all prostate cancers has shown what researchers are calling unprecedented specificity (99.99%) for detecting prostate tumor cells in tissue specimens.

Most men with prostate cancer who test below the normal PSA level and have low-risk disease still undergo aggressive treatment, researchers from The Cancer Institute of New Jersey, New Brunswick recently reported.

Despite modest increases in compensation experienced by urology and most other specialties, many provider organizations continue to operate at a significant loss, according to findings from the American Medical Group Association?s 2010 Medical Group Compensation and Financial Survey.

It is easy to underestimate in good times the consequences of excessive debt and low liquidity when times are tough, however. Like anything else, moderation is the key.

Most full solo family practices have 2,000 to 3,000 patients total in their practices.

For busy clinicians, new technologies promise savings in time as well as costs?in theory. But in practice, is this actually true? The jury is still out.

Statin drugs may lessen the risk for return of prostate cancer in individuals who have undergone radical prostatectomy.

Most biochemical recurrence of prostate cancer following radical prostatectomy occurs within 10 years, and patients who remain free from progression a decade postoperatively can be counseled that their risk of subsequent cancer-related morbidity and mortality is low.

A mandatory second opinion to interpret prostate needle biopsy prior to radical prostatectomy in a few cases results in differences that may affect therapy.

Bacillus Calmette-Guérin (has been the standard of care for bladder cancer for nearly 40 years. Little is known about BCG or its mechanism of action, however. A trial currently under way at M.D. Anderson Cancer Center, Houston, may help urologists to separate responders from nonresponders early and tailor therapy for optimal results in those who respond to the drug.

Occupational exposures in painters are associated with an elevated risk for bladder cancer, a risk that increases with years on the job.

New urology products and services from sanofi-aventis, American Medical Systems, Karl Storz Endoscopy-America, Inc., Ethicon Endo-Surgery, Cook Medical, and GE Healthcare.

A robot-assisted laparoscopic approach to partial nephrectomy maintains oncologic principles and renal function while offering several benefits compared with a conventional laparoscopic technique.

High-intensity focused ultrasound as primary therapy for localized prostate cancer can produce outcomes that equal external beam radiation therapy.

Possible new federal self-referral restrictions on radiation therapy services are being aggressively challenged by a nationwide group of integrated group practice physicians who take issue with charges that physician ownership of equipment used in the procedures results in increased and unnecessary services and Medicare costs.

Testicular cancer patients who are exposed to radiotherapy have a greater risk of being diagnosed with a subsequent non-testicular cancer, including bladder cancer.

Among studies on high-intensity focused ultrasound presented at the AUA annual meeting in San Francisco, two showed encouraging biochemical disease-free survival rates for primary treatment as well as salvage therapy.

Preliminary results from a phase III trial do not support the research hypothesis that the addition of bevacizumab (Avastin) to a regimen combining docetaxel (Taxotere) and prednisone improves survival in patients with metastatic castration-resistant prostate cancer.

Internet-based information on robotic cystectomy, much of it provided by surgeons, often overstates claims and outcomes compared to what can be supported by evidence.

The average U.S. citizen is living longer primarily because of advancements in medical care. This means a higher likelihood of needing long-term care.

The mainstay of care for men with locally advanced prostate cancer has been hormonal therapy alone, but data from a recent randomized, controlled trial comparing hormonal therapy alone with radiation added to hormonal therapy should challenge this dogma.

Men with prostate cancer who undergo robot-assisted radical prostatectomy achieve equivalent urinary and sexual function outcomes relative to their counterparts managed with open surgery.